359 related articles for article (PubMed ID: 14741762)
1. Neonatal 3,4-methylenedioxymethamphetamine (ecstasy) alters dopamine and serotonin neurochemistry and increases brain-derived neurotrophic factor in the forebrain and brainstem of the rat.
Koprich JB; Campbell NG; Lipton JW
Brain Res Dev Brain Res; 2003 Dec; 147(1-2):177-82. PubMed ID: 14741762
[TBL] [Abstract][Full Text] [Related]
2. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) alters exploratory behavior, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats.
Koprich JB; Chen EY; Kanaan NM; Campbell NG; Kordower JH; Lipton JW
Neurotoxicol Teratol; 2003; 25(5):509-17. PubMed ID: 12972064
[TBL] [Abstract][Full Text] [Related]
3. Dissociation between serotonin neurotoxicity and brain-derived neurotrophic factor induction following neonatal MDMA exposure in rats.
Piper BJ; Farelli JD; Meyer JS
Dev Neurosci; 2009; 31(1-2):90-4. PubMed ID: 19372690
[TBL] [Abstract][Full Text] [Related]
4. Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats.
Crawford CA; Williams MT; Kohutek JL; Choi FY; Yoshida ST; McDougall SA; Vorhees CV
Brain Res; 2006 Mar; 1077(1):178-86. PubMed ID: 16483555
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") on BDNF mRNA expression in rat frontal cortex and hippocampus.
Martínez-Turrillas R; Moyano S; Del Río J; Frechilla D
Neurosci Lett; 2006 Jul; 402(1-2):126-30. PubMed ID: 16644117
[TBL] [Abstract][Full Text] [Related]
6. Chronic stress enhances the corticosterone response and neurotoxicity to +3,4-methylenedioxymethamphetamine (MDMA): the role of ambient temperature.
Johnson BN; Yamamoto BK
J Pharmacol Exp Ther; 2010 Oct; 335(1):180-9. PubMed ID: 20634423
[TBL] [Abstract][Full Text] [Related]
7. Neurotoxic effects of MDMA ("ecstasy") administration to neonatal rats.
Meyer JS; Grande M; Johnson K; Ali SF
Int J Dev Neurosci; 2004; 22(5-6):261-71. PubMed ID: 15380826
[TBL] [Abstract][Full Text] [Related]
8. The involvement of brain-derived neurotrophic factor in 3,4-methylenedioxymethamphetamine-induced place preference and behavioral sensitization.
Mouri A; Noda Y; Niwa M; Matsumoto Y; Mamiya T; Nitta A; Yamada K; Furukawa S; Iwamura T; Nabeshima T
Behav Brain Res; 2017 Jun; 329():157-165. PubMed ID: 28472632
[TBL] [Abstract][Full Text] [Related]
9. Neurochemical and neurohistological alterations in the rat and monkey produced by orally administered methylenedioxymethamphetamine (MDMA).
Slikker W; Ali SF; Scallet AC; Frith CH; Newport GD; Bailey JR
Toxicol Appl Pharmacol; 1988 Jul; 94(3):448-57. PubMed ID: 2456631
[TBL] [Abstract][Full Text] [Related]
10. Altered forebrain neurotransmitter responses to immobilization stress following 3,4-methylenedioxymethamphetamine.
Matuszewich L; Filon ME; Finn DA; Yamamoto BK
Neuroscience; 2002; 110(1):41-8. PubMed ID: 11882371
[TBL] [Abstract][Full Text] [Related]
11. N-tert-butyl-alpha-phenylnitrone protects against 3,4-methylenedioxymethamphetamine-induced depletion of serotonin in rats.
Yeh SY
Synapse; 1999 Mar; 31(3):169-77. PubMed ID: 10029234
[TBL] [Abstract][Full Text] [Related]
12. A neurotoxic regimen of MDMA suppresses behavioral, thermal and neurochemical responses to subsequent MDMA administration.
Shankaran M; Gudelsky GA
Psychopharmacology (Berl); 1999 Nov; 147(1):66-72. PubMed ID: 10591870
[TBL] [Abstract][Full Text] [Related]
13. (±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain.
Hemmerle AM; Dickerson JW; Herring NR; Schaefer TL; Vorhees CV; Williams MT; Seroogy KB
J Comp Neurol; 2012 Aug; 520(11):2459-74. PubMed ID: 22237931
[TBL] [Abstract][Full Text] [Related]
14. 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity.
Williams MT; Schaefer TL; Ehrman LA; Able JA; Gudelsky GA; Sah R; Vorhees CV
Brain Res; 2005 Mar; 1039(1-2):97-107. PubMed ID: 15781051
[TBL] [Abstract][Full Text] [Related]
15. In vivo evidence for free radical involvement in the degeneration of rat brain 5-HT following administration of MDMA ('ecstasy') and p-chloroamphetamine but not the degeneration following fenfluramine.
Colado MI; O'Shea E; Granados R; Murray TK; Green AR
Br J Pharmacol; 1997 Jul; 121(5):889-900. PubMed ID: 9222545
[TBL] [Abstract][Full Text] [Related]
16. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
17. Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood.
Cohen MA; Skelton MR; Schaefer TL; Gudelsky GA; Vorhees CV; Williams MT
Synapse; 2005 Sep; 57(3):148-59. PubMed ID: 15945064
[TBL] [Abstract][Full Text] [Related]
18. (+/-)3,4-Methylenedioxymethamphetamine (MDMA) produces long-term reductions in brain 5-hydroxytryptamine in rats.
Mokler DJ; Robinson SE; Rosecrans JA
Eur J Pharmacol; 1987 Jun; 138(2):265-8. PubMed ID: 2887440
[TBL] [Abstract][Full Text] [Related]
19. Prenatal 3,4-methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in the dopaminergic and serotonergic functions in the rat.
Galineau L; Belzung C; Kodas E; Bodard S; Guilloteau D; Chalon S
Brain Res Dev Brain Res; 2005 Feb; 154(2):165-76. PubMed ID: 15707670
[TBL] [Abstract][Full Text] [Related]
20. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.
O'Loinsigh ED; Boland G; Kelly JP; O'Boyle KM
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):621-38. PubMed ID: 11371001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
